摘要
目的:观察红元胶囊用于眼眶骨折围手术期的临床疗效。方法:将眶骨骨折患者80例(80眼)随机分为两组,对照组38例(38眼),术后予甘露醇及地塞米松静点、维生素B1及甲钴胺片口服及对症治疗;治疗组42例(42眼),应用对照组口服药物,于术前及术后3d加用红元胶囊1.2g,3次/d,口服1个月。观察两组治疗后1周、2周、1个月的疗效。结果:术后1周两组视力变化无统计学意义(P>0.05),治疗组总有效率为92.86%,对照组总有效率为86.84%,两组比较,差异无统计学意义(P>0.05);术后2周,治疗组治愈率为66.67%,对照组治愈率为57.89%,两组比较,差异无统计学意义(P>0.05);术后1个月,治疗组治愈率为83.33%,对照组为60.53%,x2=5.2049,两组比较,差异有显著性(P<0.05)。结论:眼眶骨折围手术期中西医结合疗法安全有效,能够缩短术后恢复时间。
Objective: To observe clinical efficacy of the Hongyuan capsule on orbital fracture during perioperative period. Methods: 80 cases (80 eyes) were randomly divided into two groups. The control group (38 cases) was given mannitol,dexamethasone, vitamin B1,mecobalamin tablets and symptomatic treatment. The treatment group (42 cases) was given the Hongyuan capsule more preoperatively and 3 days postoperatively, 3 times daily, for 1 month. The clinical effects were observed in 1 week, 2 weeks, 1 month and 1 year. Results: In 1 week, the vision in two groups was no significant difference (P>0.05). The total efficiency in the treatment group was 92.86%, and higher than 86.84% in the control group, with no significant difference (P>0.05). In 2 weeks, the cure rate in the treatment group was 66.67%, and higher than 57.89% in the control group, with no significant difference (P>0.05). 1 month postoperatively, the cure rate in the treatment group was 83.33%, and higher than 60.53% in the control group, with a significant difference (x2=5.2049, P<0.05). Conclusion: The integrative medicine on orbital fractures during perioperative period was safe and effective, and can shorten the time of recovery.
出处
《中医临床研究》
2016年第19期80-82,共3页
Clinical Journal Of Chinese Medicine
关键词
眼眶骨折
眼钝挫伤
红元胶囊
围手术期
Orbital fracture
Ocular blunt trauma
The Hongyuan capsule
Perioperative
